Parkers Pharma has introduced Spinomax XRT, a 180-day slow-release larvicide tablet designed for sustained mosquito suppression in regions battling diseases such as malaria, Zika virus, dengue, Rift Valley fever, and chikungunya. Spearheaded by lead scientist Dr Wathek Zair, this innovation represents a crucial breakthrough in larval habitat control—offering protection in locations where…
No responses yet